v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue $ 88,395 $ 373,186 $ 341,023 $ 2,381,592
Cost of goods sold 231,837 955,003 783,656 4,959,660
Gross loss (143,441) (581,817) (442,633) (2,578,068)
Operating expenses:        
Research and development 1,335,167 1,837,510 5,870,555 3,749,714
Sales and marketing 390,684 384,748 1,529,637 1,566,790
General and administrative 4,370,684 3,000,156 10,461,733 8,446,785
Total operating expenses 6,096,535 5,222,414 17,861,925 13,763,289
Loss from operations (6,239,976) (5,804,231) (18,304,558) (16,341,357)
Other income(expense):        
Interest Income 35,557 51,792 370,387 71,389
Change in FV-Warrant Liability (10,095,960) (10,095,960)
Change in FV-Derivative Liability 3,216,000 3,216,000
Unrealized gain (loss) on marketable securities 403,996 (32,135) 602,211 (75,204)
Realized gain on marketable securities 90,812 103,000 143,344 110,490
Other income (expense), net (6,349,596) 122,657 (5,764,018) 106,675
Net loss (12,589,572) (5,681,574) (24,068,576) (16,234,682)
Preferred stock dividends (244,000) (244,000)
Accretion of discounts to redemption value of H-7 convertible preferred stock (1,165,635) (1,165,635)
Deemed Dividend (Series H-5 warrants) (199,000) (199,000)
Net loss attributable to Common Stockholders $ (14,198,207) $ (5,681,574) $ (25,677,211) $ (16,234,682)
Net loss per share, basic $ (2.99) $ (1.23) $ (5.47) $ (3.51)
Net loss per share, diluted $ (2.99) $ (1.23) $ (5.47) $ (3.51)
Weighted average common stock outstanding, basic 4,744,229 4,636,829 4,698,104 4,624,437
Weighted average common stock outstanding, diluted 4,744,229 4,636,829 4,698,104 4,624,437

Source